HSBC Holdings’s Endologix Inc ELGX Stock Holding History

HSBC Holdings’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,720	Closed	-$99K	–	2786
2016 Q4	$99K	Buy	+1,720	New	+$158K	﹤0.01%	2619

Other funds holding ELGX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

HSBC Holdings's ELGX Position: Q1 2017 in Review

HSBC Holdings sold out of Endologix Inc (ELGX) in Q1 2017, closing a stake of 1,720 shares — an estimated $99K sold.

HSBC Holdings first reported a position in ELGX in Q4 2016 and held it in 1 quarter. The position peaked at $99K in Q4 2016. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2017.

HSBC Holdings reported no remaining Endologix Inc position as of Q1 2017 after selling out during the quarter.
HSBC Holdings sold 1,720 Endologix Inc shares in Q1 2017, an estimated $99K.
HSBC Holdings first reported a position in Endologix Inc in Q4 2016 and held it in 1 quarter.
HSBC Holdings's Endologix Inc position peaked at $99K in Q4 2016.
129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.